General Clinical Research Center NIH M01RR000083 Oct 1, 1974 - Role: Co-Investigator UCSF-Gladstone Center for AIDS Research NIH P30AI027763 Sep 30, 1988 - Role: Co-Investigator Immunologic Control of Drug-resistant HIV-1 NIH R01AI052745 Sep 1, 2002 - Role: Principal Investigator Treatment Intensification for Drug-Resistant HIV NIH R21AI055273 May 1, 2003 - Role: Principal Investigator
Impact of HIV-associated inflammation on disease NIH K24AI069994 May 1, 2007 - Role: Principal Investigator The Biology of HIV Transmission NIH P01AI071713 Sep 1, 2007 - Role: Co-Investigator The impact of early antiretroviral therapy on HIV persistence and inflammation NIH R01AI087145 Sep 26, 2009 - Role: Principal Investigator NIH U19AI096109 Jul 8, 2011 - Role: Principal Investigator Therapeutic vaccination and PD-1 blockade in treated HIV disease NIH U01AI131296 Apr 1, 2017 - Role: Principal Investigatorĭelaney AIDS Research Enterprise to Cure HIV NIH UM1AI126611 Jul 14, 2016 - Role: Principal InvestigatorĭARE: Delaney AIDS Research Enterprise to find a cure. Deeks maintains a primary care clinic for people living with HIV.ĭelaney AIDS Research Enterprise to Cure HIV NIH UM1AI164560 Aug 16, 2021 - Role: Principal Investigator In addition to his translational and clinical. In 2022, he received the Lifetime Achievement in Mentoring Award from UCSF. He is listed annually as one of the world's most cited scientists for the past several years. He serves on the scientific advisory board for Science Translational Medicine and is the editor-in-chief of Current Opinion in HIV and AIDS. Deeks is a member of the American Society for Clinical Investigation (ASCI) and Association of American Physicians (AAP). In early 2020, he leveraged his HIV research program to construct the “Long-term Impact of Infection with Novel Coronavirus (LIINC)” cohort, which is now supporting dozens of studies addressing the impact of SARS-CoV-2 on health. He recently directed the amfAR Institute for HIV Cure Research. He is the contact principal investigator of DARE (the Delaney AIDS Research Enterprise), an NIH-funded international collaboratory aimed at developing therapeutic interventions to cure HIV infection. Deeks has published over 700 peer-review articles, editorials and invited reviews on these and related topics. He is also now leading a large program focused on the pathogenesis and treatment of Long COVID. He is an internationally recognized expert on HIV pathogenesis and treatment. Deeks, MD, is a Professor of Medicine in Residence at the University of California, San Francisco (UCSF) and a faculty member in the Division of HIV, Infectious Diseases and Global Medicine at Zuckerberg San Francisco General Hospital.
0 kommentar(er)
